Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Alliance Pharma Plc LSE:APH London Ordinary Share GB0031030819 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.40 0.64% 62.60 62.70 63.20 63.20 62.00 63.00 1,631,641 16:35:04
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 163.2 18.2 1.4 45.7 338

Alliance Pharma Share Discussion Threads

Showing 2226 to 2249 of 2425 messages
Chat Pages: 97  96  95  94  93  92  91  90  89  88  87  86  Older
DateSubjectAuthorDiscuss
12/11/2019
14:30
I recently put some money on BXP (generic medicines), pleased with progress so far,
but share price still well below where it should be for this fast growing company.
PE-Ratio stands ridiculously low, IMO. Some invested here in APH might be interested in BXP's progress. But as always, DYOR.

winnings1
30/10/2019
08:03
I had an interesting response from the company about the CEO cashing his options and offloading the vast majority of his shares.
Apparently the CEO knows nothing more about the fortunes of the company than a private investor and we should draw no conclusions from his complete exit from any paid for investment in the company he leads.

If the CEO knows as much as me, WTF is he doing and why are we paying him?

Lies like this annoy me - the whole tone of the reply was patronising.

If he sold because of a divorce or something else on those lines... reason for sale as "family reasons" or similar would have been OK

All we have now is a CEO who has traded out of the company he leads leaving some "profit" invested.

marksp2011
29/10/2019
13:38
For those interested in alternative Pharma stocks (shameless plug) Open Orphan AIM:ORPH a stock definitely worth keeping tabs on - Rises today and CEO Cathal Friel predicts 40% growth a year on recent podcast below with 2 million of his own money invested. They are currently on a presenting roadshow if anyone is interested hxxps://audioboom.com/posts/7361662-open-orphan-orph-ceo-cathal-friel-tells-alan-green-why-he-expects-40-percent-growth-year-on-year

The company has a four pronged strategy including a European health data collection platform - with patient clinical and genomic data. For measure GSK recently valued an Alzheimers neurologival disorder database for £300m so big money business. CCO Maurice Treacy explains on proactive https://www.youtube.com/watch?v=eFvPcwjL-m4


For those interested Maurice Treacy is holding a live webinar tomorrow 30th at 19:00 (UK time) hxxps://vtm.clickmeeting.com/orph

sunningdale1
24/10/2019
11:01
Inflection point on the chart, either back to 80 ceiling or through 70 floor... something has to give imo dyor ofc
rathean
23/10/2019
20:33
The CEO exercised a bucket load of options a few days ago and dumped most of the shares on the market
Good to see that he left a few invested (out of his profits)
As he has all the inside information it does suggest that exit would be a good idea

Alliance Pharma plc (AIM: APH), the international healthcare group, announces that it has received notice that on 7 October 2019, Peter Butterfield, Chief Executive Officer of Alliance, exercised unapproved share options over 3,137,546 ordinary shares of 1p each in the Company ("Ordinary Shares") under the Company's Share Option Plans. The average exercise price was 34.5 pence.

Following the exercise, on 7 October 2019, Mr Butterfield sold 2,791,546 Ordinary Shares at a price of 73.5 pence per share. Following these transactions, Mr Butterfield's total beneficial interest in the Group is 374,376 Ordinary Shares, representing approximately 0.07 per cent. of the Group's issued share capital.

marksp2011
23/10/2019
12:32
Where are you seeing these changes Rathean? I can't see anything on the website or here. Thanks in advance
bishan bedi
23/10/2019
11:10
Some notable changes of share ownership this morning, I wonder if something is afoot... or just someone freeing up money for Xmas imo dyor ofc.
rathean
18/10/2019
14:07
Doubled up at 71 and change. Bit of a Brexit gamble but regardless circa 70 support appears to be holding all imo dyor ofc.
rathean
09/10/2019
06:33
and another big trade. Whatever is happening can't be complete as there should be an RNS.

Part of it may be a feature article in Shares mag with a buy note. Nothing in it we didn't know but still a full page buy rec.

marksp2011
09/10/2019
06:32
Winnings
This is pretty standard stuff - it is where APH get their products from :)
They are all sole supply agreements . Nothing unusual or strange about it. APH will come out of this clean but they have been included to compel them to hand over documents.

marksp2011
08/10/2019
12:59
They sold sole distribution rights to a particular product, the buyer raised the price of that product instantly by hundreds %, without competition fears. Who took away the competition fears... Taking into account that APH specializes in the distribution of niche products, why sell that particular niche product with an 'undertaking' not to compete...? My understanding/interpretation is that the Investigation is looking into the latter...., but I could be wrong. High time we hear an outcome!
winnings1
08/10/2019
11:31
If they were fined 100% of revenue it would be �200k...APH were pretty clear. They have been wholesaling and dont set the resale price
marksp2011
08/10/2019
10:38
I am surprised at the share price rising despite the price-fixing investigation ongoing.
winnings1
08/10/2019
10:17
I agree and more to come as APH continues to deliver.
2vdm
08/10/2019
05:48
BTW Bbird I now have enough capital gain to pay for my summer holidays for 6 next summer. two weeks all inclusive in the sun.

It isn't lightening but 132% Sp growth in 5 years

20% annualised total return over 5 years versus 6.29% for the FT100 - i know what I would go for :) (data from Morningstar)

marksp2011
07/10/2019
15:28
A series of big trades. Same thing last week
10M traded.looks like some sort of rollover or trade between acciounts

marksp2011
04/10/2019
15:56
APH a dog of a share, no capital gains only small divi will buy @ 65p again, note forever, wanting money for expansion, nothing left for shareholders
has a track record. BB

black bird
02/10/2019
14:37
WOW some big deals gone through
I wonder how old they are

marksp2011
27/9/2019
11:08
Just to advise I have amended APH Company website internet address in the header, to reflect recent change, So Investor Info should be accessible by clicking on following link :
HTTps://alliancepharmaceuticals.com/investors/

mazarin
25/9/2019
13:03
www.proactiveinvestors.co.uk/companies/news/903365/alliance-pharma-star-brands-and-asia-underpin-drugs-group-s-financial-performance-903365.html
2vdm
25/9/2019
13:03
Useful summary on Proactive investor report [...]
2vdm
24/9/2019
08:36
Solid company , good results. Nice to have something like this in the portfolio with a divi which will grow over the years. Like their exposure to rapidly growing Far Eastern markets where the potential for a few of their products is massive.
cumnor
24/9/2019
07:43
Good Results, but not a word about progress in the ongoing price-fixing investigation.
winnings1
24/9/2019
06:22
Well, they didn't take long to read

Good set of numbers. Good revenue and profit growth. Falling debt and a 10% divi hike.

marksp2011
Chat Pages: 97  96  95  94  93  92  91  90  89  88  87  86  Older
Your Recent History
LSE
APH
Alliance P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230126 21:31:17